Regulation of DNA repair pathway choice during development
Regulation of DNA repair pathway choice during development
批准号:
BB/H009957/1
负责人:
Nicholas Lakin
金额:
$69.61万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --
中文摘要
遗传密码(DNA)包含了一幅蓝图,用以产生细胞以程序化的方式执行其各种功能所需的所有机制。保存这种密码对于维持正常的细胞功能至关重要。然而,DNA不断受到导致遗传密码变化的因素的攻击。当细胞复制它们的DNA (DNA复制)时,通过改变DNA构建块的序列(突变),或者通过在DNA分子中产生断裂,就会发生这种情况。有趣的是,DNA损伤也发生在严格调控的环境中,在许多正常的细胞过程中,包括免疫系统的发育和遗传信息的传递,因为细胞在减数分裂过程中分离了它们的基因组。因此,细胞已经发展出一个复杂的通路网络来检测DNA损伤,并通过DNA修复来纠正这些错误。观察结果强调了DNA修复的重要性,即这些途径中的缺陷会导致各种衰弱的临床症状,包括早衰、免疫系统衰竭、发育异常和癌症风险增加。因此,了解DNA修复将提供一些基本的生物学过程的见解,以及关于许多疾病状态的分子基础的线索。DNA双螺旋双链断裂(双链断裂;DSBs)是最具毒性的DNA损伤之一。这些可以通过直接重新连接DNA断裂来修复(非同源末端连接;NHEJ),或者使用同源DNA作为模板来恢复基因组完整性(同源定向修复;HDR)。这两种途径的组成部分很好地表征了。然而,影响细胞是否通过NHEJ或HDR修复损伤的因素仍然相对不明确。DNA修复缺陷导致多种发育异常,包括抗体产生缺陷、颅面异常和神经系统变性。尽管如此,当多细胞生物发育成各种特殊组织时,这些途径是如何被调节的,这在很大程度上仍未被探索。从细菌到人类,所有生物的DNA修复都是通过类似的机制实现的。因此,在相对简单的模式生物中研究这些途径增加了我们对这些过程如何在人类中起作用的理解。不幸的是,某些常用的模式生物缺乏人类DNA DSB修复途径的关键成分,并且没有经过发育程序进入专门的细胞类型。相比之下,居住在土壤中的变形虫盘基ostelum是一种容易生长和操纵的生物,它经历了一个相对简单的发育程序。因此,它是研究细胞类型规范和分化的常用模型。此外,我们之前的工作已经表明,这种生物中的DNA DSB修复途径比其他常用的模式生物更类似于人类。本研究的目的是利用这些观察结果,并以盘基骨柱为模型,研究DNA DSB修复途径的选择是如何在生物体的生命周期和发育过程中被调节的。除了提供Dictyostelium如何调节DNA修复途径的见解外,这些研究可能适用于包括人类在内的其他高等生物如何实现这些过程。
英文摘要
The genetic code (DNA) contains a blueprint to produce all the machinery required for a cell to perform its various functions in a programmed manner. Preservation of this code is critical to maintain normal cellular functions. However, DNA is under continual attack from agents that cause changes in the genetic code. This can occur when cells copy their DNA (DNA replication), through changes in the sequence of DNA building blocks (mutation), or by creating breaks in the DNA molecule. Interestingly, DNA damage also occurs in a tightly regulated context during a number of normal cellular processes including development of the immune-system and transfer of genetic information as cells segregate their genomes in a process know as meiosis. Therefore, cells have developed a complex network of pathways to detect DNA damage when it occurs and correct these faults by DNA repair. The importance of DNA repair is underscored by the observations that defects in these pathways leads to a variety of debilitating clinical symptoms including premature ageing, immune-system failure, developmental abnormalities and increased cancer risk. Therefore, understanding DNA repair will provide insights into several fundamental biological processes in addition to clues regarding the molecular basis of a number of disease states. Breaks in both strands of the DNA double helix (double strand breaks; DSBs) are one of the most toxic varieties of DNA damage. These can be repaired by directly re-joining DNA breaks (non-homologous end-joining; NHEJ), or by using homologous DNA as a template to restore genome integrity (homology-directed repair; HDR). The components of these two pathways are well characterised. However, the factors that influence whether cells repair damage by NHEJ or HDR remains relatively ill defined. Defects in DNA repair lead to a variety of developmental abnormalities including defective antibody production, cranial-facial abnormalities and degeneration of the nervous system. Despite this, how these pathways are regulated as multi-cellular organisms develop into a variety of specialised tissues remains largely unexplored. DNA repair is achieved by similar mechanisms in all organisms from bacteria to humans. Therefore, studying these pathways in relatively simple model organisms has increased our understanding of how these processes work in humans. Unfortunately, certain commonly used model organisms lack key components of human DNA DSB repair pathways and do not undergo a developmental program into specialised cell types. In contrast, the soil dwelling amoeba Dictyostelium is an easily grown and manipulated organism that undergoes a relatively simple developmental program. As such, it is a commonly used model to study cell type specification and differentiation. In addition, our previous work has illustrated that DNA DSB repair pathways in this organism are more similar to humans than other commonly used model organisms. The aims of this research are to exploit these observations and use Dictyostelium as a model to study how DNA DSB repair pathway choice is regulated in the context of an organism's life cycle and developmental program. In addition to providing insights into how DNA repair pathways are regulated in Dictyostelium, these studies will likely be applicable to how these processes are achieved in other higher organisms including humans.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/978-1-62703-302-2_16
发表时间:
2013-01-01
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Couto, Anne-Marie C, Lakin, Nicholas D, Pears, Catherine J]
通讯作者:
Pears, Catherine J
PARP regulates nonhomologous end joining through retention of Ku at double-strand breaks.
PARP通过在双链断裂中保留KU来调节非同源末端。
DOI:
10.1083/jcb.201012132
发表时间:
2011-08-08
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Couto CA, Wang HY, Green JC, Kiely R, Siddaway R, Borer C, Pears CJ, Lakin ND]
通讯作者:
Lakin ND
Emerging models for DNA repair: Dictyostelium discoideum as a model for nonhomologous end-joining.
DNA 修复的新兴模型:盘基网柄菌作为非同源末端连接的模型。
DOI:
10.1016/j.dnarep.2014.01.008
发表时间:
2014
期刊:
DNA repair
影响因子:
3.8
作者:
[Pears CJ]
通讯作者:
Pears CJ
Regulation of DNA repair by histone ADP-ribosylation
-
批准号:MR/W017350/1
-
项目类别:Research Grant
-
资助金额:$86.32万
-
财政年份:2022
-
负责人:Nicholas Lakin
-
依托单位:
Defining the role of PARPs in the DNA repair and genome stability
-
批准号:MR/V00896X/1
-
项目类别:Research Grant
-
资助金额:$102.01万
-
财政年份:2021
-
负责人:Nicholas Lakin
-
依托单位:
Defining the role of ADP-ribosyltransferases in DNA repair and genome stability
-
批准号:MR/P018963/1
-
项目类别:Research Grant
-
资助金额:$50.37万
-
财政年份:2017
-
负责人:Nicholas Lakin
-
依托单位:
Defining the function of histone ADP-ribosylation in DNA repair and genome integrity
-
批准号:MR/P028284/1
-
项目类别:Research Grant
-
资助金额:$51.29万
-
财政年份:2017
-
负责人:Nicholas Lakin
-
依托单位:
Modelling ADP-ribosyltransferases as therapeutic targets in cancer therapy
-
批准号:MR/L000164/1
-
项目类别:Research Grant
-
资助金额:$51.39万
-
财政年份:2014
-
负责人:Nicholas Lakin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
解码精母细胞特异5’UTR元件调控DNA损伤修复基因MSH5翻译挽救减数分裂障碍的研究
-
批准号:82371607
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:李铮
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
PHF19上调EXD2促进DNA损伤修复增加胶质瘤放疗抵抗的作用与机制研究
-
批准号:32100591
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:何江
-
依托单位:
STRIPAK复合物调控DNA损伤修复及肠癌化疗耐药的功能与机制研究
-
批准号:32070710
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:安利伟
-
依托单位:
拟南芥辅助共激活因子ADA2b与染色质相关因子ADIP1互作参与DNA损伤响应的机制研究
-
批准号:32000493
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:江洁明
-
依托单位:
XPF蛋白的乙酰化修饰在DNA损伤修复中的功能与作用机制研究
-
批准号:31970664
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:刘婷
-
依托单位:
长链非编码RNA调控DNA损伤修复参与乳腺癌化疗耐药的机制研究
-
批准号:31801144
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:周博
-
依托单位:
miR-1193和DNA-PKcs协同致死脑胶质瘤细胞分子机制研究
-
批准号:31701179
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2017
-
负责人:张晶
-
依托单位:
MRN复合物在CK2-HP1β-Tip60 DNA损伤修复通路中作用的研究
-
批准号:31100558
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:刘志坚
-
依托单位:
细胞内DNA triplex 介导的转录偶联修复与突变发生的分子机制研究
-
批准号:30471958
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2004
-
负责人:陈志文
-
依托单位: